guest ::
| Home > Publications database > Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. > print |
| Home > Publications database > Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. > print |
| 001 | 167797 | ||
| 005 | 20240229133549.0 | ||
| 024 | 7 | _ | |a 10.1016/j.isci.2021.102128 |2 doi |
| 024 | 7 | _ | |a pmid:33659885 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC7895756 |2 pmc |
| 024 | 7 | _ | |a altmetric:99191003 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-00559 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 050 |
| 100 | 1 | _ | |a Ruiz-Pérez, María Victoria |b 0 |
| 245 | _ | _ | |a Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. |
| 260 | _ | _ | |a St. Louis |c 2021 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1615279557_26330 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Many metabolic pathways, including lipid metabolism, are rewired in tumors to support energy and biomass production and to allow adaptation to stressful environments. Neuroblastoma is the second deadliest solid tumor in children. Genetic aberrations, as the amplification of the MYCN-oncogene, correlate strongly with disease progression. Yet, there are only a few molecular targets successfully exploited in the clinic. Here we show that inhibition of fatty acid synthesis led to increased neural differentiation and reduced tumor burden in neuroblastoma xenograft experiments independently of MYCN-status. This was accompanied by reduced levels of the MYCN or c-MYC oncoproteins and activation of ERK signaling. Importantly, the expression levels of genes involved in de novo fatty acid synthesis showed prognostic value for neuroblastoma patients. Our findings demonstrate that inhibition of de novo fatty acid synthesis is a promising pharmacological intervention strategy for the treatment of neuroblastoma independently of MYCN-status. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |x 0 |f POF IV |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a biological sciences |2 Other |
| 650 | _ | 7 | |a cancer |2 Other |
| 650 | _ | 7 | |a cell biology |2 Other |
| 650 | _ | 7 | |a molecular biology |2 Other |
| 700 | 1 | _ | |a Sainero-Alcolado, Lourdes |b 1 |
| 700 | 1 | _ | |a Oliynyk, Ganna |b 2 |
| 700 | 1 | _ | |a Matuschek, Isabell |b 3 |
| 700 | 1 | _ | |a Balboni, Nicola |b 4 |
| 700 | 1 | _ | |a Ubhayasekera, S J Kumari A |b 5 |
| 700 | 1 | _ | |a Snaebjornsson, Marteinn Thor |0 P:(DE-He78)7b7131e0870c28d432e48873d295460f |b 6 |u dkfz |
| 700 | 1 | _ | |a Makowski, Kamil |b 7 |
| 700 | 1 | _ | |a Aaltonen, Kristina |b 8 |
| 700 | 1 | _ | |a Bexell, Daniel |b 9 |
| 700 | 1 | _ | |a Serra, Dolors |b 10 |
| 700 | 1 | _ | |a Nilsson, Roland |b 11 |
| 700 | 1 | _ | |a Bergquist, Jonas |b 12 |
| 700 | 1 | _ | |a Schulze, Almut |0 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1 |b 13 |u dkfz |
| 700 | 1 | _ | |a Arsenian-Henriksson, Marie |b 14 |
| 773 | _ | _ | |a 10.1016/j.isci.2021.102128 |g Vol. 24, no. 2, p. 102128 - |0 PERI:(DE-600)2927064-9 |n 2 |p 102128 |t iScience |v 24 |y 2021 |x 2589-0042 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:167797 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)7b7131e0870c28d432e48873d295460f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)94ae391f53fb9285e1b68f9930615af1 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Signalling pathways, cell and tumor biology |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2020-08-31 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2020-08-31 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version) |0 LIC:(DE-HGF)CCBYNCNDNV |2 V:(DE-HGF) |b DOAJ |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-08-31 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-08-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-08-31 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2020-08-31 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2020-08-31 |
| 920 | 1 | _ | |0 I:(DE-He78)A410-20160331 |k A410 |l Tumor Metabolismus und Microenvironment |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A410-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|